Synthetic iNKT cell-agonists as vaccine adjuvants--finding the balance.
The unique position of invariant natural killer T (iNKT) cells at the interface of the innate and adaptive arms of the immune response, combined with their ability to modulate the activity of antigen-presenting cells, has led to their intensive investigation as a means of augmenting the immune respo...
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Journal article |
| Taal: | English |
| Gepubliceerd in: |
2010
|